Arixtra and Risperdal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arixtra (fondaparinux sodium) and Risperdal (risperidone). Common drug interactions include palpitations among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Arixtra and Risperdal. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.



On Jul, 10, 2026

43 people who take Arixtra and Risperdal together, and have interactions are studied.

Arixtra and Risperdal drug interactions.

What are the common drug interactions of Arixtra and Risperdal, by gender? *:

female:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Pleural effusion (water on the lungs)
  3. Pneumonia
  4. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  5. Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
  6. Psychotic disorder
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Rales (an abnormal respiratory sound characterized by fine crackles)
  9. Red blood cell count decreased
  10. Renal failure acute (rapid kidney dysfunction)

male:

  1. Anaemia (lack of blood)
  2. C-reactive protein increased
  3. Postoperative wound complication
  4. Traumatic haematoma (a blood clot in body due to trauma)
  5. Blood pressure decreased
  6. Cardiac arrest
  7. Cardiac enzymes increased
  8. Coagulopathy (blood's ability to clot is impaired)
  9. Coma (state of unconsciousness lasting more than six hours)
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the common drug interactions of Arixtra and Risperdal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anxiety
  2. Cholecystitis (infection of gallbladder)
  3. Emotional distress
  4. General physical health deterioration (weak health status)
  5. Injury
  6. Mesenteric vein thrombosis (blood clot in mesenteric vein)
  7. Pain
  8. Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Splenic vein thrombosis (blood clot in splenic vein)

40-49:

  1. Chills (felling of cold)
  2. Overdose
  3. Pneumonia
  4. Psychotic disorder

50-59:

  1. Anaemia (lack of blood)
  2. C-reactive protein increased
  3. Haemoglobin decreased
  4. Muscle haemorrhage (bleeding in muscle)
  5. Post procedural haemorrhage (post procedural bleeding)
  6. Postoperative wound complication
  7. Traumatic haematoma (a blood clot in body due to trauma)
  8. Death
  9. Fall
  10. Haematoma (collection of blood outside the blood vessels)

60+:

  1. Hypotension (abnormally low blood pressure)
  2. Anaemia (lack of blood)
  3. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  4. Gastric ulcer (stomach ulcer)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Haematemesis (vomiting of blood)
  7. Haematochezia (passage of stools containing blood)
  8. Haemoglobin decreased
  9. Hypertensive crisis
  10. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)

What are the existing conditions these people have? *

  1. Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 8 people, 18.60%
  2. Pain: 8 people, 18.60%
  3. Diabetes: 6 people, 13.95%
  4. Dementia (madness): 5 people, 11.63%
  5. Chest Pain: 5 people, 11.63%
  6. Agitation (state of anxiety or nervous excitement): 5 people, 11.63%
  7. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 4 people, 9.30%
  8. Iron Deficiency: 4 people, 9.30%
  9. High Blood Pressure: 4 people, 9.30%
  10. Arrhythmias (irregular heartbeat): 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and Risperdal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arixtra and Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arixtra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arixtra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Risperdal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fondaparinux sodium and risperidone (the active ingredients of Arixtra and Risperdal, respectively), and Arixtra and Risperdal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: